TuHURA Biosciences (HURA)
NASDAQ:HURA
Want to see HURA full AI Analyst Report?
Total Valuation
TuHURA Biosciences has a market cap or net worth of $195.19M. The enterprise value is $192.07M.
Market Cap$195.19M
Enterprise Value$192.07M
Share Statistics
TuHURA Biosciences has 63,578,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,578,530
Owned by Insiders3.94%
Owned by Institutions0.68%
Financial Efficiency
TuHURA Biosciences’s return on equity (ROE) is -1.44 and return on invested capital (ROIC) is -146.98%.
Return on Equity (ROE)-1.44
Return on Assets (ROA)-1.10
Return on Invested Capital (ROIC)-146.98%
Return on Capital Employed (ROCE)-1.48
Revenue Per Employee0.00
Profits Per Employee-1.58M
Employee Count19
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of TuHURA Biosciences is ―. TuHURA Biosciences’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio1.73
Price to Fair Value1.73
Price to FCF-1.31
Price to Operating Cash Flow-3.57
PEG Ratio0.03
Income Statement
In the last 12 months, TuHURA Biosciences had revenue of 0.00 and earned -30.06M in profits. Earnings per share was -0.63.
Revenue0.00
Gross Profit0.00
Operating Income-31.80M
Pretax Income-30.06M
Net Income-30.06M
EBITDA-29.36M
Earnings Per Share (EPS)-0.63
Cash Flow
In the last 12 months, operating cash flow was -41.22M and capital expenditures -145.72K, giving a free cash flow of -41.36M billion.
Operating Cash Flow-41.22M
Free Cash Flow-41.36M
Free Cash Flow per Share-0.65
Dividends & Yields
TuHURA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.07
52-Week Price Change-26.02%
50-Day Moving Average1.63
200-Day Moving Average1.95
Relative Strength Index (RSI)75.58
Average Volume (3m)215.15K
Important Dates
TuHURA Biosciences upcoming earnings date is Apr 1, 2026, Before Open (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend Date―
Financial Position
TuHURA Biosciences as a current ratio of 0.78, with Debt / Equity ratio of 2.40%
Current Ratio0.78
Quick Ratio0.78
Debt to Market Cap0.01
Net Debt to EBITDA0.11
Interest Coverage Ratio-50.85
Taxes
In the past 12 months, TuHURA Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
TuHURA Biosciences EV to EBITDA ratio is -1.13, with an EV/FCF ratio of -1.20.
EV to Sales0.00
EV to EBITDA-1.13
EV to Free Cash Flow-1.20
EV to Operating Cash Flow-1.20
Balance Sheet
TuHURA Biosciences has $3.62M in cash and marketable securities with $502.67K in debt, giving a net cash position of $3.12M billion.
Cash & Marketable Securities$3.62M
Total Debt$502.67K
Net Cash$3.12M
Net Cash Per Share$0.05
Tangible Book Value Per Share$0.21
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for TuHURA Biosciences is $8.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.33
Price Target Upside171.34% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast99.21%